Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

01/24 15:59   SYRIAN ENVOY TO UN REGRETS OPPOSITION CRITICIZES CONDUCT OF SYRIA DEAL GUARANTOR COUNTRIES
 
01/24 15:58   SYRIAN ENVOY TO UN AL-JAAFARI: TURKEY PLAYS NEGATIVE ROLE IN SYRIAN SETTLEMENT PROCESS
 
01/24 15:57   SYRIAN ENVOY TO UN: IRAN PLAYED IMPORTANT ROLE IN SIGNING FINAL DOCUMENT OF INTRA-SYRIAN MEETING IN ASTANA
 
01/24 15:57   Poland requests gas from Nord Stream 2, not planning to extend contract with Russia - OMV
 
01/24 15:56   Gazprom not planning to sell Gascade stake - Deputy CEO Medvedev (Part 2)
 
01/24 15:56   Russians see trend of improving relations with Europe, support it - poll
 
01/24 15:51   SYRIAN GOVERNMENT READY TO SIT DOWN WITH OPPOSITION FOR SAVING COUNTRY - AL-JAAFARI
 
01/24 15:48   Syrian opposition hopes Russia will continue its involvement in establishing peace in Syria
 
01/24 15:46   Moscow, Tehran, Ankara to cooperate on Astana platform for settling Syria crisis - statement
 
01/24 15:41   Dadin's appeal with Russian Constitutional Court shall not be upheld - presidential envoy (Part 2)
 


 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

January 24, 2017
 
15:48
Syrian opposition hopes Russia will continue its involvement in establishing peace in Syria
 
15:46
Moscow, Tehran, Ankara to cooperate on Astana platform for settling Syria crisis - statement
 
15:41
Dadin's appeal with Russian Constitutional Court shall not be upheld - presidential envoy (Part 2)
 
15:36
Rosatom applies to bid in South African nuclear plant tender - Likhachev
 
15:36
Daily Headline News for January 24, 2017
 
15:35
NATO delegation arrives in Ukraine
 
15:33
 
15:31
Armenian PM brings new proposals on Russian capital involvement to Moscow
 
15:30
Official exchange rates for CIS and Baltic nations as of 24.01.2017
 
15:25
SOKOLOV: HEAD OF EGYPT'S AVIATION MINISTRY TO VISIT RUSSIA EARLY FEBRUARY, INCLUDING TO DISCUSS REINSTATING FLIGHTS
 
15:24
Guarantor countries acknowledge Syria's integrity, sovereignty - joint statement
 
15:19
LIKHACHEV: ROSATOM HAS APPLIED TO BID AT TENDER TO BUILD NUCLEAR POWER PLANT IN SOUTH AFRICA
 
15:19
Gazprom to seek reciprocal injunctions on OPAL to safeguard revenue (Part 2)
 
15:18
Iran, Russia, Turkey support Syrian opposition's wish to partake in Feb 8 negotiations in Geneva - statement
 
 more headlines 



Interviews
 

.
OSCE Chairperson-in-Office, Austrian Foreign Minister Sebastian Kurz has given an interview to Interfax in which he speaks about his vision of the Ukrainian settlement and the role of the SMM OSCE in it, about conditions under which EU sanctions against Russia can be lifted at any time and tells about what he values in his Russian counterpart Sergei Lavrov.

more
.
.
Pakistani Minister of Planning, Development and Reform Ahsan Iqbal has given an interview to Interfax in the wake of his visit to Moscow in which he speaks about prospects of interaction between Russia and Pakistan in various spheres, prospects of Russias joining the China-Pakistan economic corridor project, the settlement in Afghanistan and prospects of Pakistans joining the Nuclear Non-proliferation Treaty.

more
.
.
Head of the delegation of the International Committee of the Red Cross (ICRC) in Russia, Belarus and Moldova Magne Barth has explained the position of the ICRC on interaction with Russian military in Syria. Earlier the Russian Defense Ministry called the ICRC reaction regarding the death of two Russian medical workers in a strike on a Russian military hospital in Syrias Aleppo cynical.

more

 
  
 ©   1991—2017   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100